X4 Pharmaceuticals to Participate in the 36th Annual Piper Sandler Healthcare Conference
X4 Pharmaceuticals (Nasdaq: XFOR), focused on rare immune system diseases, announces its participation in the 36th Annual Piper Sandler Healthcare Conference in New York. The company will engage in a fireside chat on Tuesday, December 3, 2024, at 11:00 AM ET at the Lotte New York Palace. The event will be available via webcast through X4's investor relations website, with a replay option post-conference. Management will also be available for one-on-one meetings with investors, which can be arranged through Piper Sandler representatives.
X4 Pharmaceuticals (Nasdaq: XFOR), concentrata sulle malattie rare del sistema immunitario, annuncia la sua partecipazione alla 36ª Conferenza Sanitaria Annuale Piper Sandler a New York. L'azienda parteciperà a una chiacchierata informale martedì 3 dicembre 2024, alle 11:00 ET presso il Lotte New York Palace. L'evento sarà disponibile in diretta streaming attraverso il sito web delle relazioni con gli investitori di X4, con un'opzione di riproduzione dopo la conferenza. La direzione sarà anche disponibile per incontri uno-a-uno con gli investitori, che possono essere organizzati tramite i rappresentanti di Piper Sandler.
X4 Pharmaceuticals (Nasdaq: XFOR), centrada en enfermedades raras del sistema inmunológico, anuncia su participación en la 36ª Conferencia Anual de Salud Piper Sandler en Nueva York. La empresa participará en una charla informal el martes 3 de diciembre de 2024, a las 11:00 AM ET en el Lotte New York Palace. El evento estará disponible a través de un webcast en el sitio web de relaciones con inversores de X4, con una opción de repetición después de la conferencia. La dirección también estará disponible para reuniones individuales con los inversores, que se pueden organizar a través de los representantes de Piper Sandler.
X4 제약 (Nasdaq: XFOR), 희귀 면역계 질환에 집중하는 회사, 뉴욕에서 열리는 제36회 파이퍼 샌들러 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 회사는 2024년 12월 3일 화요일 오전 11:00 ET에 롯데 뉴욕 팰리스에서 진행되는 대화에 참여할 예정입니다. 해당 행사에는 X4의 투자자 관계 웹사이트를 통해 웹캐스트로 참여할 수 있으며, 컨퍼런스 종료 후 재생 옵션이 제공됩니다. 경영진은 또한 투자자와의 일대일 미팅을 위해 대기 중이며, 이는 파이퍼 샌들러 대표를 통해 조율할 수 있습니다.
X4 Pharmaceuticals (Nasdaq: XFOR), spécialisée dans les maladies rares du système immunitaire, annonce sa participation à la 36e Conférence Annuelle de Santé Piper Sandler à New York. L'entreprise participera à une discussion informelle le mardi 3 décembre 2024, à 11h00 ET au Lotte New York Palace. L'événement sera disponible en direct via le site Web des relations avec les investisseurs de X4, avec une option de rediffusion après la conférence. La direction sera également disponible pour des réunions individuelles avec les investisseurs, qui peuvent être organisées par l'intermédiaire des représentants de Piper Sandler.
X4 Pharmaceuticals (Nasdaq: XFOR), die sich auf seltene Erkrankungen des Immunsystems konzentriert, gibt ihre Teilnahme an der 36. Jahreskonferenz Piper Sandler Healthcare in New York bekannt. Das Unternehmen wird am Dienstag, den 3. Dezember 2024, um 11:00 Uhr ET an einer informellen Gesprächstunde im Lotte New York Palace teilnehmen. Die Veranstaltung wird über einen Livestream über die Investor Relations-Website von X4 verfügbar sein, mit einer Wiederholungsoption nach der Konferenz. Das Management wird auch für persönliche Gespräche mit Investoren zur Verfügung stehen, die über die Vertreter von Piper Sandler organisiert werden können.
- None.
- None.
BOSTON, Nov. 26, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that management will participate in the 36th Annual Piper Sandler Healthcare Conference, taking place in New York, NY on December 3-5, 2024.
| 36th Annual Piper Sandler Healthcare Conference | |
| Date: | Tuesday, December 3, 2024 |
| Time: | 11:00AM ET |
| Format: | Fireside Chat |
| Location: | Lotte New York Palace, New York |
| Webcast Link | |
This live webcast will also be accessible through “events & presentations” page of the investors section of X4 Pharmaceuticals’ website. After the conclusion of the conference, a replay of this webcast will be available through the same link.
The Company will be available for one-on-one meetings during this conference. Interested investors should contact their Piper Sandler representative to request meetings.
About X4 Pharmaceuticals
X4 is delivering progress for patients by developing and commercializing innovative therapies for those with rare diseases of the immune system and significant unmet needs. Leveraging our expertise in CXCR4 and immune system biology, we have successfully developed mavorixafor, which has received U.S. approval as XOLREMDI® (mavorixafor) capsules in its first indication. We are also evaluating the use of mavorixafor in additional potential indications. X4 corporate headquarters are in Boston, Massachusetts and our research center of excellence is in Vienna, Austria. For more information, please visit our website at www.x4pharma.com.
Company Contact:
José Juves
Head of Corporate & Patient Affairs
jose.juves@x4pharma.com
Investor Contact:
Daniel Ferry
Managing Director, LifeSci Advisors
daniel@lifesciadvisors.com
(617) 430-7576
FAQ
When is X4 Pharmaceuticals (XFOR) presenting at the Piper Sandler Healthcare Conference 2024?
Where can I watch X4 Pharmaceuticals' (XFOR) Piper Sandler Conference presentation?
What type of presentation will XFOR give at the 2024 Piper Sandler Healthcare Conference?
How can investors arrange meetings with X4 Pharmaceuticals (XFOR) at the Piper Sandler Conference?
